Apichart Suksamrarn Selected Research

Apichart Suksamrarn Research Topics

Disease

25	Neoplasms (Cancer) 12/2023 - 04/2008
20	Inflammation (Inflammations) 03/2023 - 12/2011
11	Breast Neoplasms (Breast Cancer) 01/2023 - 07/2009
10	Brain Ischemia (Cerebral Ischemia) 04/2023 - 01/2017
8	Hepatocellular Carcinoma (Hepatoma) 11/2022 - 04/2008
7	Infarction (Infarctions) 04/2023 - 01/2017
6	Cognitive Dysfunction 12/2023 - 01/2020
6	Alzheimer Disease (Alzheimer's Disease) 04/2021 - 05/2013
5	Necrosis 08/2023 - 12/2003
5	Neuroblastoma 01/2021 - 01/2015
5	Osteoporosis 01/2021 - 09/2011
5	Body Weight (Weight, Body) 05/2020 - 03/2012
4	Reperfusion Injury 04/2023 - 01/2017
4	Middle Cerebral Artery Infarction (Middle Cerebral Artery Syndrome) 10/2022 - 01/2020
4	Atherosclerosis 08/2021 - 03/2016
4	Colonic Neoplasms (Colon Cancer) 01/2021 - 05/2012
4	Insulin Resistance 07/2020 - 03/2012
4	Wounds and Injuries (Trauma) 11/2013 - 01/2008
3	Cholangiocarcinoma 12/2023 - 01/2014
3	Hypertension (High Blood Pressure) 01/2022 - 12/2019
2	Acute Lung Injury 08/2023 - 01/2022
2	Pneumonia (Pneumonitis) 08/2023 - 04/2018
2	Cerebral Infarction 04/2023 - 01/2020
2	Non-alcoholic Fatty Liver Disease 03/2023 - 07/2020
2	Neuroinflammatory Diseases 04/2022 - 09/2018
2	Neurodegenerative Diseases (Neurodegenerative Disease) 04/2022 - 12/2016
2	Hyperlipidemias (Hyperlipidemia) 08/2021 - 11/2016
2	Cardiovascular Diseases (Cardiovascular Disease) 08/2021 - 10/2016
2	Infections 08/2021 - 10/2014
2	Thalassemia 01/2021 - 03/2013
2	Squamous Cell Carcinoma of Head and Neck 02/2017 - 01/2017
2	Amyloid Plaque 01/2016 - 01/2015

Drug/Important Bio-Agent (IBA)

13	DiarylheptanoidsIBA 06/2022 - 07/2009
9	hexahydrocurcuminIBA 12/2023 - 05/2012
8	AntioxidantsIBA 01/2023 - 12/2011
8	Estrogens (Estrogen)FDA Link 01/2021 - 07/2009
7	CurcuminIBA 01/2022 - 04/2008
7	andrographolideIBA 11/2020 - 01/2012
6	cucurbitacin BIBA 10/2019 - 01/2010
5	Proteins (Proteins, Gene)FDA Link 08/2022 - 01/2017
4	CytokinesIBA 12/2023 - 11/2020
4	Neuroprotective AgentsIBA 10/2022 - 09/2018
4	salicylhydroxamic acid (SHAM)IBA 10/2022 - 03/2012
4	Phytoestrogens (Phytoestrogen)IBA 06/2022 - 03/2012
4	Reactive Oxygen Species (Oxygen Radicals)IBA 04/2022 - 12/2011
4	Amyloid (Amyloid Fibrils)IBA 04/2021 - 01/2015
4	DiterpenesIBA 05/2018 - 07/2010
4	Chalcone (Benzalacetophenone)IBA 02/2018 - 01/2012
3	Phosphotransferases (Kinase)IBA 12/2023 - 08/2014
3	Interleukin-6 (Interleukin 6)IBA 08/2023 - 08/2022
3	nonivamideIBA 03/2023 - 07/2019
3	ChitosanIBA 01/2023 - 04/2022
3	Angiotensin IIIBA 01/2023 - 03/2016
3	Sorafenib (BAY 43-9006)FDA Link 11/2022 - 01/2021
3	neferineIBA 10/2022 - 05/2020
3	dihydrocapsaicinIBA 10/2021 - 01/2017
3	Antiviral Agents (Antivirals)IBA 03/2021 - 06/2003
3	LipidsIBA 07/2020 - 03/2012
3	Fluorouracil (Carac)FDA LinkGeneric 01/2019 - 05/2012
3	EnzymesIBA 12/2018 - 09/2013
3	LipopolysaccharidesIBA 09/2018 - 11/2015
2	tiliacorinineIBA 12/2023 - 01/2014
2	AlkaloidsIBA 12/2023 - 01/2017
2	oxocrebanineIBA 08/2023 - 08/2022
2	Anti-Inflammatory Agents (Anti-Inflammatories)IBA 08/2023 - 01/2022
2	Galactose (Galactopyranose)FDA LinkGeneric 06/2023 - 04/2022
2	Aluminum ChlorideIBA 06/2023 - 04/2022
2	Toll-Like Receptor 4IBA 03/2023 - 01/2020
2	STAT3 Transcription Factor (Signal Transducer and Activator of Transcription 3)IBA 03/2023 - 03/2021
2	NADPH Oxidases (NAD(P)H oxidase)IBA 01/2023 - 01/2017
2	AlginatesIBA 12/2022 - 04/2022
2	NanocapsulesIBA 12/2022 - 04/2022
2	Nimodipine (Modus)FDA LinkGeneric 10/2022 - 12/2021
2	Nitric Oxide Synthase Type II (Inducible Nitric Oxide Synthase)IBA 08/2022 - 01/2014
2	Hemoglobins (Hemoglobin)IBA 06/2022 - 03/2013
2	Cholinergic Agents (Cholinergics)IBA 04/2022 - 04/2021
2	morinIBA 02/2022 - 01/2020
2	NG-Nitroarginine Methyl Ester (L-NAME)IBA 01/2022 - 12/2019
2	ASPP 049IBA 11/2021 - 06/2013
2	GlucocorticoidsIBA 05/2021 - 01/2020
2	Dexamethasone (Maxidex)FDA LinkGeneric 04/2021 - 01/2020
2	LuciferasesIBA 03/2021 - 12/2017
2	InterferonsIBA 03/2021 - 12/2017
2	GlobinsIBA 01/2021 - 03/2013
2	Evans Blue (Blue, Evans)FDA Link 06/2020 - 01/2017
2	Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA 05/2020 - 01/2019
2	Rosmarinic AcidIBA 12/2019 - 04/2018
2	Vasodilator Agents (Vasodilators)IBA 12/2019 - 01/2015
2	Cyclin D1IBA 03/2019 - 09/2016
2	Telomerase (Telomerase Reverse Transcriptase)IBA 12/2018 - 01/2010
2	Phosphodiesterase 5 InhibitorsIBA 10/2018 - 01/2015
2	cyanidinIBA 09/2018 - 12/2016
2	Glucose (Dextrose)FDA LinkGeneric 12/2017 - 03/2012
2	Nitric Oxide (Nitrogen Monoxide)FDA Link 01/2017 - 01/2014
2	cyanidin-3-O-beta-glucopyranosideIBA 10/2016 - 03/2016
2	Atorvastatin (Lipitor)FDA Link 09/2016 - 03/2016

Therapy/Procedure

10	Therapeutics 12/2022 - 01/2012
3	Thai Traditional Medicine 02/2023 - 11/2016
2	Drug Therapy (Chemotherapy) 04/2022 - 01/2020
2	Intraperitoneal Injections 01/2020 - 05/2010